Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL
- 1 April 2008
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet Neurology
- Vol. 7 (4), 310-318
- https://doi.org/10.1016/s1474-4422(08)70046-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cholinergic Neuronal Deficits in CADASILStroke, 2007
- Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementiaNeurobiology of Aging, 2006
- Loss of Cholinergic Pathways in Vascular Dementia of the Binswanger TypeDementia and Geriatric Cognitive Disorders, 2005
- Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patientsBrain, 2004
- A Two-Year Clinical Follow-Up Study in 80 CADASIL SubjectsStroke, 2004
- Efficacy and Tolerability of Donepezil in Vascular DementiaStroke, 2003
- General Measures of CognitionInternational Psychogeriatrics, 2003
- Development of Cognitive Instruments for Use in Clinical Trials of Antidementia DrugsAlzheimer Disease & Associated Disorders, 1997
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975